Myoclonic attacks induced by L-dopa and bromocryptin in Parkinson patients: a sleep EEG study
- PMID: 77316
- DOI: 10.1007/BF00314716
Myoclonic attacks induced by L-dopa and bromocryptin in Parkinson patients: a sleep EEG study
Abstract
Six patients with Parkinson's disease developed nocturnal myoclonic attacks after prolongued treatment with L-Dopa which were electroencephalographically recorded. These symptoms persisted after treatment with 2 bromo-alpha-ergocryptin (Bromocryptin), a dopamine receptor agonist, which was substituted for L-Dopa. Bromocryptin is known to have no pre- or postsynaptic effect on serotonin metabolism. It is proposed that these myoclonic phenomena are the expression of the hypersensitivity of denervated catecholamine receptors in the brainstem to the stimulation of L-Dopa and Bromocryptin. This thesis differs with previous suggestions that serotonin plays a major role in the genesis of myoclonic seizures in Parkinsonian patients treated with L-Dopa.
Similar articles
-
L-dopa induced "serotonin syndrome" in a parkinsonian patient on bromocriptine.J Clin Psychopharmacol. 1986 Jun;6(3):194-5. doi: 10.1097/00004714-198606000-00022. J Clin Psychopharmacol. 1986. PMID: 3711372 No abstract available.
-
EEG sleep patterns in Parkinsonian patients treated with bromocryptine and L-dopa: a comparative study.J Neural Transm. 1979;45(4):307-16. doi: 10.1007/BF01247147. J Neural Transm. 1979. PMID: 490153
-
[Myoclonic attacks induced by bromocriptine in Parkinsonian patients].Harefuah. 1979 Jan 15;96(2):90-2. Harefuah. 1979. PMID: 478382 Hebrew. No abstract available.
-
Treatment of Parkinson's disease with dopamine agonists: a review.Am J Med Sci. 1979 Jul-Aug;278(1):65-76. doi: 10.1097/00000441-197907000-00008. Am J Med Sci. 1979. PMID: 39452 Review.
-
Treatment of Parkinson's disease: levodopa as the first choice.J Neurol. 2002 Sep;249 Suppl 2:II19-24. doi: 10.1007/s00415-002-1204-4. J Neurol. 2002. PMID: 12375059 Review.
Cited by
-
The clinical heterogeneity of drug-induced myoclonus: an illustrated review.J Neurol. 2017 Aug;264(8):1559-1566. doi: 10.1007/s00415-016-8357-z. Epub 2016 Dec 16. J Neurol. 2017. PMID: 27981352 Free PMC article. Review.
-
Drug-induced myoclonus: frequency, mechanisms and management.CNS Drugs. 2004;18(2):93-104. doi: 10.2165/00023210-200418020-00003. CNS Drugs. 2004. PMID: 14728056 Review.
-
Clinical neurophysiology of Parkinson's disease and parkinsonism.Clin Neurophysiol Pract. 2022 Jun 30;7:201-227. doi: 10.1016/j.cnp.2022.06.002. eCollection 2022. Clin Neurophysiol Pract. 2022. PMID: 35899019 Free PMC article. Review.
-
Drug-Induced Myoclonus: A Systematic Review.Medicina (Kaunas). 2025 Jan 15;61(1):131. doi: 10.3390/medicina61010131. Medicina (Kaunas). 2025. PMID: 39859113 Free PMC article.